EPSTEIN ROBERT S 4

What Happened

• Robert S. Epstein, a director of Veracyte, Inc. (VCYT), was granted 5,272 restricted stock units (RSUs) on June 11, 2026. The grant was recorded at $0.00 per share (no cash paid). These RSUs represent an award, not an immediate purchase of common stock; they convert to shares only upon vesting.

Key Details

• Transaction date: 2026-06-11; Filing date (Form 4): 2026-06-15 (filed within the two business‑day reporting window).
• Grant amount: 5,272 RSUs; reported acquisition price: $0.00.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnote: RSUs vest in full on the first anniversary of the grant (around June 11, 2027) or immediately prior to the company’s next annual meeting if earlier; they also vest in full upon a change in control of the company.
• Transaction type code: A = Award/Grant.

Context

• RSU grants are a common form of director compensation and do not represent an immediate sale or purchase of stock; their economic value materializes only if and when the units vest and convert to shares.
• This filing does not indicate any immediate market action by the insider (no sale or open‑market purchase reported).